KATHLEEN COUGHLIN: Open Payments
NPI 1780222539 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 12 payments from 9 companies in 2025. Trend: 2023 $865 · 2024 $305 · 2025 $367
Food & beverage: $335Education: $32
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $128 |
| Celgene Corporation | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Legend Biotech USA Inc. | 2 | $32 |
| Incyte Corporation | 1 | $23 |
| BeOne Medicines USA, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
Products named: BREYANZI, CARVYKTI, NIKTIMVO, BRUKINSA, Xtandi, Fabhalta, FRUZAQLA, REZUROCK.
Industry payments across MA — which companies pay providers there.
